by Massimo Sandal (Agenzia Zoe)
Â
Takeaway messages
-
Interim analysis of the TRANSFORM clinical trial shows that CAR-T cell therapy can substantially increase large B-cell lymphoma (LBCL) event-free survival in refractory/relapsed patients.
Why this matters
-
Patients...